CCB
AEON icon

Cutter & Co Brokerage’s AEON Biopharma AEON Stock Holding History

Cutter & Co Brokerage’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-195
Closed -$7.58K – 186
2024
Q4 		$7.58K Hold
195
– – ﹤0.01% 207
2024
Q3 		$14.7K Buy
+195
New +$17.2K ﹤0.01% 212

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Cutter & Co Brokerage's AEON Position: Q1 2025 in Review

Cutter & Co Brokerage sold out of AEON Biopharma (AEON) in Q1 2025, closing a stake of 195 shares — an estimated $7.58K sold.

Cutter & Co Brokerage first reported a position in AEON in Q3 2024 and held it in 2 quarters. The position peaked at $14.7K in Q3 2024. 16 funds tracked by Wall St. Rank hold AEON as of Q1 2025.

  • Cutter & Co Brokerage reported no remaining AEON Biopharma position as of Q1 2025 after selling out during the quarter.
  • Cutter & Co Brokerage sold 195 AEON Biopharma shares in Q1 2025, an estimated $7.58K.
  • Cutter & Co Brokerage first reported a position in AEON Biopharma in Q3 2024 and held it in 2 quarters.
  • Cutter & Co Brokerage's AEON Biopharma position peaked at $14.7K in Q3 2024.
  • 16 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2025.

Based on Cutter & Co Brokerage's 13F filing for Q1 2025, filed 1 May 2025.